The CelESTial project is a partnership between the Estonian Centre for Synthetic Biology (ECSB) at the University of Tartu and the Novo Nordisk Foundation Center for Biosustainability at the Technical University of Denmark. Our main aim is to create a research and development platform for the sustainable bio-manufacturing of high-value chemicals and pharmaceuticals using cell factories.
The ESCB was founded in the spring of 2016 by combining the research efforts of the Institute of Technology at the University of Tartu with a collection of other Estonian laboratories that conduct research related to synthetic biology. The majority of the research groups at the Institute of Technology have been established within the past 15 years with the help of highly competitive foreign grants and fellowships, including private research funding from the Howard Hughes Medical Institute (United States) and The Wellcome Trust (UK), and public funding from a number of H2020 projects (ERC, Centres of Excellence). The ECSB was founded and is currently based at the Institute of Technology, yet it also acts as an umbrella organization for a consortium of synthetic biology labs in Estonia. Its greater aim, however, is to develop a research and technology development center of its own.